Position in HLN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,308
+$1,224 QoQ
Shares Held
569
+39.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#525
of 639 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MOTCO holds $34,070 across 7 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
657 | $10,433 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
516 | $8,271 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
311 | $7,653 | |
| 4 | HLN |
Haleon plc
This page
|
569 | $5,308 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
42 | $1,422 | |
| 6 | ZTS |
Zoetis Inc.
|
9 | $646 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
2 | $337 |
All Filings in HLN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,308 | 569 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,084 | 408 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $4,124 | 408 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,659 | 408 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,230 | 408 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,169 | 308 | Shares | Sole | 2025-05-07 | |
| 2023-12-31 | $345 | 42 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $957 | 115 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $393 | 47 | Shares | Sole | 2023-08-04 | |
| 2022-09-30 | $2,436 | 400 | Shares | Sole | 2022-11-03 | |
| No filing history on record for this holder in this stock. | ||||||